RU2018137034A - Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae - Google Patents
Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae Download PDFInfo
- Publication number
- RU2018137034A RU2018137034A RU2018137034A RU2018137034A RU2018137034A RU 2018137034 A RU2018137034 A RU 2018137034A RU 2018137034 A RU2018137034 A RU 2018137034A RU 2018137034 A RU2018137034 A RU 2018137034A RU 2018137034 A RU2018137034 A RU 2018137034A
- Authority
- RU
- Russia
- Prior art keywords
- immunogen
- pcv2
- mycoplasma hyopneumoniae
- use according
- replicating
- Prior art date
Links
- 241000204045 Mycoplasma hyopneumoniae Species 0.000 title claims 13
- 229960005486 vaccine Drugs 0.000 title claims 9
- 208000015181 infectious disease Diseases 0.000 title claims 7
- 241001673669 Porcine circovirus 2 Species 0.000 title 1
- 230000002163 immunogen Effects 0.000 claims 19
- 230000003362 replicative effect Effects 0.000 claims 11
- 241001148567 Lawsonia intracellularis Species 0.000 claims 5
- 241001465754 Metazoa Species 0.000 claims 5
- 241001533384 Circovirus Species 0.000 claims 4
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 claims 3
- 241000282898 Sus scrofa Species 0.000 claims 3
- 241000700605 Viruses Species 0.000 claims 3
- 239000002671 adjuvant Substances 0.000 claims 3
- 230000002238 attenuated effect Effects 0.000 claims 3
- 239000002480 mineral oil Substances 0.000 claims 3
- 235000010446 mineral oil Nutrition 0.000 claims 3
- 239000007908 nanoemulsion Substances 0.000 claims 3
- 238000011321 prophylaxis Methods 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- 101710159752 Poly(3-hydroxyalkanoate) polymerase subunit PhaE Proteins 0.000 claims 1
- 101100382437 Porcine circovirus 2 Cap gene Proteins 0.000 claims 1
- 101710130262 Probable Vpr-like protein Proteins 0.000 claims 1
- 241000282887 Suidae Species 0.000 claims 1
- 210000004207 dermis Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 241000701447 unidentified baculovirus Species 0.000 claims 1
- 238000002255 vaccination Methods 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16161997.8 | 2016-03-23 | ||
| EP16161997 | 2016-03-23 | ||
| PCT/EP2017/056831 WO2017162741A1 (en) | 2016-03-23 | 2017-03-22 | A combination vaccine against pcv2 virus and mycoplasma hyopneumoniae infection |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2022116197A Division RU2022116197A (ru) | 2016-03-23 | 2017-03-22 | Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2018137034A true RU2018137034A (ru) | 2020-04-23 |
| RU2018137034A3 RU2018137034A3 (cg-RX-API-DMAC10.html) | 2020-06-26 |
Family
ID=55589754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018137034A RU2018137034A (ru) | 2016-03-23 | 2017-03-22 | Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20190105385A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP3432919A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP6907227B2 (cg-RX-API-DMAC10.html) |
| CN (1) | CN108697782A (cg-RX-API-DMAC10.html) |
| BR (1) | BR112018069100A2 (cg-RX-API-DMAC10.html) |
| RU (1) | RU2018137034A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2017162741A1 (cg-RX-API-DMAC10.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2844168C1 (ru) * | 2020-10-29 | 2025-07-28 | Интервет Интернэшнл Б.В. | Комбинированная вакцина для защиты свиней от различных заболеваний |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7354106B2 (ja) * | 2017-12-04 | 2023-10-02 | インターベット インターナショナル ベー． フェー． | レプリコン粒子および油性アジュバントによるワクチン接種 |
| CA3085535A1 (en) | 2017-12-22 | 2019-06-27 | Hipra Scientific, S.L.U. | Intradermal combination vaccine against mycoplasma and porcine circovirus |
| CN114364398B (zh) * | 2019-09-12 | 2025-08-22 | 英特维特国际股份有限公司 | 用于皮内施用的联合疫苗 |
| EP4138892A1 (en) | 2020-04-20 | 2023-03-01 | Intervet International B.V. | A vaccine to protect against mycoplasma hyopneumoniae |
| MX2022013080A (es) * | 2020-04-20 | 2022-11-10 | Intervet Int Bv | Una combinacion de vacunas para el tratamiento profilactico de un cerdo. |
| CN115887636B (zh) * | 2022-01-18 | 2026-07-03 | 武汉科前生物股份有限公司 | 猪圆环病毒2型、猪肺炎支原体、猪链球菌三联灭活疫苗及其制备方法 |
| AU2024402296A1 (en) | 2023-12-19 | 2026-05-28 | Intervet International B.V. | Low-energy electron irradiation-inactivated mollicutes |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990014837A1 (en) * | 1989-05-25 | 1990-12-13 | Chiron Corporation | Adjuvant formulation comprising a submicron oil droplet emulsion |
| PL1651265T3 (pl) * | 2003-07-24 | 2008-10-31 | Merial Ltd | Formulacje szczepionek zawierających emulsję olej w wodzie |
| KR20110132416A (ko) * | 2004-04-05 | 2011-12-07 | 화이자 프로덕츠 인코포레이티드 | 미세유체화된 수중유 유화액 및 백신 조성물 |
| CA2587321A1 (en) | 2005-01-13 | 2006-07-20 | Boehringer Ingelheim Vetmedica Gmbh | Improved prrs vaccines |
| US8834891B2 (en) * | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
| AR054822A1 (es) * | 2005-07-07 | 2007-07-18 | Sanofi Pasteur | Emulsion inmuno adyuvante |
| CN101277717A (zh) | 2005-09-09 | 2008-10-01 | 英特威国际有限公司 | Pcv-2疫苗 |
| CA2635430A1 (en) | 2005-12-29 | 2007-08-23 | Boehringer Ingelheim Vetmedica, Inc. | Use of a pcv2 immunogenic composition for lessening clinical symptoms in pigs |
| PT2094872T (pt) | 2006-12-15 | 2017-04-27 | Boehringer Ingelheim Vetmedica Inc | Tratamento de porcos seropositivos para o anticorpo anti-pcv2 com antigénio de pcv2 |
| TWI449533B (zh) * | 2008-04-18 | 2014-08-21 | Intervet Int Bv | 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗 |
| US8728487B2 (en) | 2011-01-20 | 2014-05-20 | Hua Wu | Attenuated live vaccine for prevention of porcine reproductive and respiratory syndrome |
| EP2753354A4 (en) * | 2011-09-09 | 2015-04-15 | Nanobio Corp | SUB-VACCINE IN NANOEMULSION FORM FOR RESPIRATORY SYNZYTIAL VIRUS |
| UA114503C2 (uk) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
| UA114504C2 (uk) * | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
| US9457073B2 (en) | 2012-09-26 | 2016-10-04 | University Of Manitoba | Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity |
| CN104043118A (zh) * | 2013-03-11 | 2014-09-17 | 普莱柯生物工程股份有限公司 | 猪prrsv、猪肺炎支原体和pvc-2抗原在制备疫苗中的应用 |
| CN103263666B (zh) * | 2013-05-24 | 2019-07-16 | 北京大北农科技集团股份有限公司动物医学研究中心 | 猪圆环病毒2型、猪支原体肺炎二联灭活疫苗及其制备方法 |
| WO2015082457A1 (en) * | 2013-12-03 | 2015-06-11 | Intervet International B.V. | Vaccine against lawsonia intracellularis and porcine circovirus 2 |
-
2017
- 2017-03-22 BR BR112018069100-3A patent/BR112018069100A2/pt active Search and Examination
- 2017-03-22 US US16/086,690 patent/US20190105385A1/en not_active Abandoned
- 2017-03-22 WO PCT/EP2017/056831 patent/WO2017162741A1/en not_active Ceased
- 2017-03-22 JP JP2018549447A patent/JP6907227B2/ja not_active Expired - Fee Related
- 2017-03-22 EP EP17711241.4A patent/EP3432919A1/en active Pending
- 2017-03-22 RU RU2018137034A patent/RU2018137034A/ru unknown
- 2017-03-22 CN CN201780014561.9A patent/CN108697782A/zh active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2844168C1 (ru) * | 2020-10-29 | 2025-07-28 | Интервет Интернэшнл Б.В. | Комбинированная вакцина для защиты свиней от различных заболеваний |
Also Published As
| Publication number | Publication date |
|---|---|
| US20190105385A1 (en) | 2019-04-11 |
| RU2018137034A3 (cg-RX-API-DMAC10.html) | 2020-06-26 |
| JP2019509300A (ja) | 2019-04-04 |
| BR112018069100A2 (pt) | 2019-01-29 |
| CN108697782A (zh) | 2018-10-23 |
| EP3432919A1 (en) | 2019-01-30 |
| WO2017162741A1 (en) | 2017-09-28 |
| JP6907227B2 (ja) | 2021-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019509300A5 (cg-RX-API-DMAC10.html) | ||
| RU2010112939A (ru) | Снижение сопутствующих инфекций у свиней с помощью антигена pcv2 | |
| MX2007011268A (es) | Composiciones inmunogeneticas que comprende lawsonia intracelularis. | |
| JP2015512449A5 (cg-RX-API-DMAC10.html) | ||
| AR069216A1 (es) | Composicion para provocar una respuesta inmune anti-mycoplasma hyopneumoniae y metodos | |
| JP2015512448A5 (cg-RX-API-DMAC10.html) | ||
| RU2014140107A (ru) | Вакцина mycoplasma hyopneumoniae | |
| RU2014140106A (ru) | Комбинированная вакцина pcv/mycoplasma hyopneumoniae | |
| RU2019122996A (ru) | Комбинированная вакцина для свиней | |
| RU2017124240A (ru) | СПОСОБ ПОЛУЧЕНИЯ ГОТОВОЙ К ПРИМЕНЕНИЮ КОМБИНИРОВАННОЙ ВАКЦИНЫ ПРОТИВ PCV2/M.hyo | |
| MX2020006662A (es) | Vacuna combinada intradermica contra mycoplasma y circovirus porcino. | |
| BR112018069100A2 (pt) | uma vacina combinada contra a infecção por vírus pcv2 e mycoplasma hyopneumoniae | |
| EA202091690A1 (ru) | Иммуногенная композиция, содержащая стафилококковые антигены | |
| MX2022003090A (es) | Vacuna combinada para ser administrable intradermicamente. | |
| RU2018127403A (ru) | Поливалентная вакцина против hyo и ее применение | |
| JP2023025210A5 (cg-RX-API-DMAC10.html) | ||
| RU2019136252A (ru) | Вакцины, содержащие патогены свиней, для ассоциированного несмешанного применения | |
| DK3076997T3 (en) | SVINEVACCINE v PRRS AND LAWSONIA INTRACELLULARIS | |
| BR112016012435A8 (pt) | vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2 | |
| RU2008144180A (ru) | Вакцина против микоплазмы и prrsv | |
| RU2018137033A (ru) | Вакцина для внутрикожного применения против инфекции вируса pcv2 и prrs | |
| RU2022116197A (ru) | Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae | |
| JP2019512518A5 (cg-RX-API-DMAC10.html) | ||
| RU2018137036A (ru) | Комбинированная вакцина против инфекции вирусами pcv2 и prrs, содержащая альбумин | |
| RU2017130457A (ru) | Вакцина для применения против субклинической инфекции lawsonia у свиней |